Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 464
Immune Disorders Drugs 194
Cardiovascular Drugs 153
Biopharmaceuticals 132
Infectious Diseases Drugs 121
Central Nervous System Drugs 104
Drug Discovery 102
Endocrine and Metabolic Disorders Drugs 102
Clinical Trials 94
Musculoskeletal Disorders Drugs 93
Pharmaceuticals 87
Leukemia Drugs 82
Hematological Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 65
Dermatological Drugs 58
Diabetes Drugs 54
Skin Cancer Drugs 50
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 40
Respiratory Drugs 38
Immunosuppressive Drugs 36
Gastrointestinal Drugs 34
Drug Delivery 32
Infusions and Injectables 31
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Pharmaceutical Manufacturing 27
Analgesics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 22
Antibiotics 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Prostate Cancer Drugs 16
Urological Disorders Drugs 16
Schizophrenia Drugs 16
Cancer Vaccines 14
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Uterine Cancer Drugs 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 5
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

2,382 Results (Page 88 of 120)
- Relevance
  Sort by

Asia-Pacific Oral Anti-Diabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
70 Pages
Asia Pacific

From

€4143EUR$4,750USD£3,609GBP

Oral Anti-Diabetic Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029

 Report
February 2024
150 Pages
Global

From

€4143EUR$4,750USD£3,609GBP

Japan Oral Anti-Diabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
70 Pages
Japan

From

€4143EUR$4,750USD£3,609GBP

India Oral Anti-Diabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
70 Pages
India

From

€4143EUR$4,750USD£3,609GBP

New Zealand Oral Anti-Diabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
70 Pages
New Zealand

From

€4143EUR$4,750USD£3,609GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Latin America Oral Anti-Diabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
70 Pages
Latin America

From

€4143EUR$4,750USD£3,609GBP

Protein Inhibitors Market Report 2025

 Report
April 2025
175 Pages
Global

From

€3917EUR$4,490USD£3,411GBP

Central Nervous System Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

 Report
January 2026
185 Pages
Global

From

€3925EUR$4,500USD£3,419GBP

Prion Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

 Report
January 2026
180 Pages
Global

From

€3925EUR$4,500USD£3,419GBP

Dermatology Drugs Market Analysis & Forecast 2024-2034: Market By Application; By Route Of Administration; By Distribution Channel; and By Region

 Report
October 2023
145 Pages
Global

From

€2748EUR$3,150USD£2,393GBP

Dermatological Therapeutics Market Analysis & Forecast 2024-2034: Market By Drug Class; By Application; and By Region

 Report
October 2023
145 Pages
Global

From

€2748EUR$3,150USD£2,393GBP

Graft Versus Host Disease Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2023
112 Pages
Global

From

€3500EUR$4,298USD£3,155GBP

Headache Disorders Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3917EUR$4,490USD£3,411GBP

Global Cell Based Immunotherapy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

 Report
May 2025
110 Pages
Global

From

€4143EUR$4,750USD£3,609GBP

Drug Discovery Technologies Market - Global Forecast 2026-2032

 Report
January 2026
194 Pages
Global

From

€3436EUR$3,939USD£2,992GBP

GLP-1 Receptor Agonist Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3917EUR$4,490USD£3,411GBP

Claudin 18.2-Targeted Immunotherapy: A Landscape Analysis of Stakeholders, Drug Modalities, Pipeline and Business Opportunities from An Industry Perspective

 Report
August 2023
267 Pages
Global

From

€2150EUR$2,640USD£1,938GBP

Cyclic Peptides Market - Global Forecast 2026-2032

 Report
January 2026
184 Pages
Global

From

€3436EUR$3,939USD£2,992GBP

Small Molecule Drug Discovery - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
115 Pages
Global

From

€4143EUR$4,750USD£3,609GBP

Multiple Myeloma Market Size, Share & Industry Trends Analysis Report By End User, By Disease Type (Active Multiple Myeloma and Smoldering Multiple Myeloma), By Drug Type, By Regional Outlook and Forecast, 2023-2029

 Report
April 2023
213 Pages
Global

From

€3140EUR$3,600USD£2,735GBP

2,382 Results (Page 88 of 120)
- 1
- 86
- 87
- 88
- 89
- 90

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.